Organ-age protein clocks face comparison with brain and physical-function measures

A study published October 2 in Aging Cell finds that blood-based estimates of organ aging are associated with subsequent mortality, but several measures of brain structure, cognition and respiratory function show stronger associations. The comparison addresses a central question for longevity research: how much useful information do newer molecular clocks provide alongside other ways of assessing aging?

Researchers examined the Lothian Birth Cohort 1936, comparing protein-based clocks for 11 organs with molecular, imaging and functional measures. The observational analysis included 861 participants and 444 deaths over approximately 16 years of follow-up. It evaluates relationships with survival; it does not demonstrate that changing a clock score extends life.

Comparing measures in the same people

Participants were born in 1936 and lived in Scotland at recruitment. The biomarkers used in this analysis were collected when participants were approximately 73 years old. Studying people of nearly the same age helps researchers examine differences that a birth date alone cannot explain, although it also limits conclusions about younger populations.

Among the protein clocks, the liver, immune system and heart showed the largest mortality associations. In models adjusted for age and sex, a one-standard-deviation increase in the liver age measure corresponded to a mortality hazard ratio of 1.43, with a 95% confidence interval of 1.30–1.58.

That is a relative comparison within the study population. It is neither a 43-percentage-point increase in the probability of death nor a prediction of how many years an individual has left.

Several other measures had larger associations. These included the DNA-methylation clock GrimAge2, smaller brain volumes, poorer respiratory function and lower cognitive performance. GrimAge2 had the largest individual association reported in the comparison.

What organ clocks contribute

The approach builds on research published in Nature in December 2023. That earlier work used plasma proteins to estimate aging differences across 11 organs in five cohorts totaling 5,676 adults. It demonstrated that protein patterns associated with particular organs could contain information about disease and mortality.

An organ clock combines measurements into a statistical estimate. Its age gap describes how a person's protein profile compares with the expected profile at their chronological age. It does not directly observe every biological process inside an organ, and different clocks can capture different aspects of health.

The new study advances that work by comparing organ clocks with other kinds of measurements in the same cohort. This matters because a marker can correlate with mortality while adding relatively little information once related measures are considered.

When the researchers modeled the aging biomarkers together, total brain volume, white-matter hyperintensity volume, cognition and walking time retained statistically significant independent associations with mortality. That result supports investigating complementary measurements rather than assuming a single molecular estimate captures the whole aging process.

Association leaves clinical questions open

The findings do not establish a preferred screening package. A stronger association in a research model does not by itself show that ordering a test improves decisions, prevents disability or prolongs survival. Those applications require separate evaluation.

The study's narrow birth cohort and geographic setting also matter. Results in Scottish adults assessed in their seventies may not transfer directly to people at different ages or in other populations. Statistical adjustment can address measured differences, but observational research cannot eliminate every alternative explanation for an association.

The outcome was death from any cause. Whether organ clocks provide additional information about particular causes of death remains unresolved. Nor does this analysis establish that an intervention-induced reduction in organ age represents a meaningful health improvement.

For healthspan research, the practical contribution is a clearer benchmark. New aging measures need comparison with cognition, mobility, physiological function and other established assessments. Their eventual value will depend on whether the additional information helps preserve health and independence.